Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand.
Drug Deliv. 2023 Dec;30(1):2234099. doi: 10.1080/10717544.2023.2234099.
Itraconazole (ICZ) was prepared in a self-microemulsifying (SM) gel. This gel was intended for use in the oral mucosa, where low volume and flow of saliva result in limited solubility and absorption of drugs that are poorly water-soluble. The drug-loaded gel formulation (ICZ-SM) was selected as a clear solution in the ternary phase diagram to improve the solubility of ICZ. Seven ratios (S1-S7) were prepared by mixing polyoxyl 35 castor oils (P35), a medium chain with a blend of mono-, di-, and triglycerides (MCT), and water. Phase separation of large-sized emulsions by countering with artificial saliva were observed in dilution tests for the formulation contained MCT, P35, and water at the ratios of 70:20:10 (S1), 10:80:10 (S3), and 20:60:20 (S4). Formulations in the ratios of 15:50:35 (S5) and 19:43:38 (S6) produced strong ICZ-SM gels, as shown by rheology tests, whereas the formulations at the ratios of 30:60:10 (S2) and 10:43:47 (S7) exhibited no elasticity. A model of zero-order kinetic (S5) and first-order kinetic (S6) were found to best fit the release kinetics of ICZ from the gels. Time-killing assays revealed that S5 and S6 required less time compared with S2 and the ICZ solution. Furthermore, S5 exhibited the highest increase in cell uptake compared with S2, S6, and the ICZ solution. These findings suggest that the ICZ-SM gel was a free polymer capable of delivering an ICZ for the treatment of oral candidiasis, and that ICZ-SM gels applied locally exhibit enhanced absorption into cells.
伊曲康唑(ICZ)被制备成自微乳(SM)凝胶。这种凝胶旨在用于口腔黏膜,在口腔黏膜中,唾液的体积和流量较少,导致药物的溶解度和吸收有限,而这些药物的水溶性较差。载药凝胶制剂(ICZ-SM)被选为三元相图中的澄清溶液,以提高 ICZ 的溶解度。通过混合聚氧乙烯 35 蓖麻油(P35)、含有单、二和三甘油酯的中链混合油(MCT)和水,制备了七种比例(S1-S7)。在稀释试验中,观察到含有 MCT、P35 和水的比例为 70:20:10(S1)、10:80:10(S3)和 20:60:20(S4)的制剂会发生大尺寸乳液的相分离,用人工唾液对抗。流变学试验表明,比例为 15:50:35(S5)和 19:43:38(S6)的制剂产生了强的 ICZ-SM 凝胶,而比例为 30:60:10(S2)和 10:43:47(S7)的制剂则没有弹性。发现零级动力学(S5)和一级动力学(S6)模型最适合拟合凝胶中 ICZ 的释放动力学。时杀试验表明,S5 和 S6 与 S2 和 ICZ 溶液相比,需要的时间更少。此外,与 S2、S6 和 ICZ 溶液相比,S5 显示出对细胞摄取的最高增加。这些发现表明,ICZ-SM 凝胶是一种能够输送 ICZ 用于治疗口腔念珠菌病的游离聚合物,局部应用的 ICZ-SM 凝胶显示出增强的细胞吸收。